GENERAL MEETING PREVIOUS SPEAKER

Francis
Collins
WORK
National Institutes of Health (NIH)

Two decades of breathtaking progress in genomics – but the best is yet to come

GENERAL MEETING PREVIOUS SPEAKER

Dr. Marco
Marra
WORK
Michael Smith Genome Sciences Centre

Towards a Canadian national program for genomic profiling of treatment resistant cancers

GENERAL MEETING PREVIOUS SPEAKER

Elodie
Ghedin
WORK
New York University

Characterizing influenza virus diversity within and across infected hosts, and the interactions of microbes in the respiratory tract, to better understand the dynamics of viral transmission

GENERAL MEETING PREVIOUS SPEAKER

Richard
M. Myers
WORK
HudsonAlpha Institute for Biotechnology

How allelic variation and gene expression changes contribute to human traits, including diseases, behaviors and other phenotypes

GENERAL MEETING PREVIOUS SPEAKER

Luis
Diaz
WORK
Johns Hopkins Hospital

Clinical development of tumor-derived DNA as a biomarker for cancer screening, early detection, monitoring and measurement of early residual disease.

GENERAL MEETING PREVIOUS SPEAKER

Elaine
Mardis
WORK
Nationwide Children's Hospital

Co-Executive Director of the institute for Genomic Medicine at Nationwide Children's Hospital and the Nationwide Foundation: Endowed Chair of Genomic Medicine

previous arrow
next arrow
Slider

ABOUT

The General Meeting is AGBT’s flagship event for bringing together global leaders, researchers, and innovators.

Advances in Genome Biology and Technology (AGBT) delivers a premier experience where heads of labs, institutions, businesses, financial analysts and other high-level stakeholders come together to advance the field and drive game-changing innovation. Significant scientific advances are announced and showcased, science and industry forge enduring partnerships, and significant investments and notable acquisitions are made.

The meeting format includes daytime plenary sessions that feature invited speakers and abstract-selected talks that highlight cutting-edge research across the broad landscape of genomics. The evening concurrent session includes experimental and computational approaches for effectively utilizing the latest DNA sequencing technologies.

DATES
March 1–4, 2021

LOCATION
Orlando, FL

2019 DEMOGRAPHICS

1033

Attendees

177

Universities and Governments

213

Companies

98

CEOS, CMOS, and CSOS

2020 Sponsors

2021 Sponsorship opportunities will open mid-August

ORGANIZING COMMITTEE

Penelope Bonnen

As an Associate Professor at Baylor College of Medicine, Dr. Bonnen is applying her acumen in bioinformatics and human genetics to gene discovery studies for an array of phenotypes and diseases including disorders caused by mitochondrial dysfunction and cancer. The Bonnen lab develops and applies methods for analyzing next-generation sequence data and interpretation of human […]

READ FULL BIO

Federica Di Palma

Federica Di Palma, is a Professor at the University of East Anglia in the United Kingdom and the Founder and Director of Science is Global strategy and consulting. She is passionate about exploring and preserving Biodiversity around the world. She leads a number of multidisciplinary research programmes which use genomics approaches to understand how evolutionary […]

READ FULL BIO

Kimberly Doheny

Dr. Kimberly Doheny is an Associate Professor of Genetic Medicine and Pathology at the Johns Hopkins University School of Medicine.  She is Director of the Center for Inherited Disease Research, Co-Director of Johns Hopkins Genomics, Co-Director of the Kennedy Krieger Institute Intellectual Developmental Disabilities Research Center Genomics Core and Director of the Laboratory Genetics and […]

READ FULL BIO

Stacey Gabriel

Institute Scientist and Senior Director of the Genomics Platform, Broad Institute of MIT and Harvard Stacey Gabriel is Senior Director of the Genomics Platform at Broad Institute, and has led platform development, execution and operation since the Institute’s founding. She is also Chair of Professional Scientists and serves on the Institute’s Executive Leadership Team. Gabriel […]

READ FULL BIO

Eric D. Green

Dr. Eric Green is the Director of the National Human Genome Research Institute (NHGRI) at the U.S. National Institutes of Health (NIH). He is the third NHGRI Director, having been appointed by NIH Director Dr. Francis Collins in 2009. Dr. Green has been at the Institute for more than 25 years, during which he has […]

READ FULL BIO

Martin Hirst

Dr. Hirst is a Senior Scientist and Head of Epigenomics at Canada’s Michael Smith Genome Sciences Centre at BC Cancer, Associate Professor in the Department of Microbiology and Immunology and Associate Director of the Michael Smith Laboratory at the University of British Columbia (UBC). His research focuses on understanding epigenetic dysfunction in cancer and his laboratory […]

READ FULL BIO

Christopher E. Mason

Dr. Christopher Mason is an Associate Professor of Genomics, Physiology, and Biophysics at Weill Cornell Medicine and the Director of the WorldQuant Initiative for Quantitative Prediction, as well as an affiliate of Memorial Sloan Kettering Cancer Center (MSKCC), Rockefeller University, Harvard Medical School, and Yale Law School. The Mason laboratory develops and deploys new biochemical […]

READ FULL BIO

John D. McPherson

Dr. McPherson is the Deputy Director of the UCD Comprehensive Cancer Center and Professor, Department of Biochemistry and Molecular Medicine. He has deep expertise in DNA sequencing and cancer genomics through his involvement in the Human Genome Project and large-scale tumor sequencing as a founding member of the International Cancer Genome Consortium. Within the ICGC, […]

READ FULL BIO

Stephen B. Montgomery

Stephen Montgomery’s laboratory at Stanford University studies genetic effects on gene regulation and gene expression to identify the molecular and cellular mechanisms which define human traits. They focus on understanding the effects of genome variation on cellular phenotypes and cellular modeling of disease through genomic approaches such as next generation RNA sequencing in combination with […]

READ FULL BIO

Len Pennacchio

Dr. Len Pennacchio is a Senior Scientist at the Lawrence Berkeley Laboratory (LBL), Deputy Director of the DOE Joint Genome Institute, and Adjunct Professor at the University of California Berkeley.  He received his PhD in Genetics from Stanford University in 1998 under Rick Myers and then served as a DOE Alexander Hollaender Distinguished Fellow at […]

READ FULL BIO

Beth Shapiro

Beth Shapiro is an evolutionary biologist who specializes in the genetics of ice age animals and plants. As Professor of Ecology and Evolutionary Biology at UC Santa Cruz and HHMI Investigator, Beth uses DNA recovered from bones and other remains to study how species evolved through time and how human activities have affected and continue […]

READ FULL BIO

Michael Zody

Dr. Michael Zody is a computational biologist with over 15 years of experience writing bioinformatic software, analyzing genomic and transcriptomic sequence data, and managing engineers and researchers. He serves as the Scientific Director of Computational Biology at the New York Genome Center. He started his career at the Whitehead Institute Center for Genome Research (now […]

READ FULL BIO

Attend

Submit an abstract or apply to attend AGBT’s flagship event. Spaces are limited.

Testimonials

AGBT is always the most important meeting I attend all year. The cutting edge scientific talks and the networking makes tremendous opportunities possible.

2019 AGBT Attendee

As it was my first time, I now know why AGBT is considered the best genomics meeting in the world…Every aspect of the conference was a highlight. Getting a cross-section of the current trends, the talks, the vendors,  the networking…everything.

2019 AGBT Attendee

I loved speaking to vendors and learning more about their new tech and how it could be applied to my lab…So many engaging talks and new connections.

2019 AGBT Attendee